Home/Corbus Pharmaceuticals/Dr. Dominic Smethurst, MA MRCP

DD

Dr. Dominic Smethurst, MA MRCP

Chief Medical Officer

Corbus Pharmaceuticals

Therapeutic Areas

Oncology Metabolic Disease Obesity

Corbus Pharmaceuticals Pipeline

Drug	Indication	Phase
CRB-701	Nectin-4 expressing solid tumors (e.g., HNSCC, Cervical Cancer, mUC)	Phase 1
CRB-701 (CSPC)	Cervical Cancer	Phase 3
CRB-913	Obesity and related conditions	Phase 1

Leadership Team at Corbus Pharmaceuticals

Yuval Cohen, Ph.D.

Chief Executive Officer and Director

Sean Moran, CPA, MBA

Chief Financial Officer

Ian Hodgson, BSc (Hons), Ph.D.

Chief Operating Officer

View full Corbus Pharmaceuticals profile